In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acambis PLC

Division of Sanofi
www.acambis.com

Latest From Acambis PLC

Stockwatch: The commercial paradox of Ebola

There are two factors that limit the ability of the Ebola virus to become a global public health tragedy: its inefficient method of transmission between humans; and its natural reservoir, which seems to be bats located in distal east Africa. These and other facets of the disease paradoxically make the Ebola virus a positive public relations opportunity for big pharmaceutical companies, but a loss-making opportunity for their small biotechnology brethren.

Infectious Diseases Cancer

$930bn later, R&D is still a pancake

In the past eight years (2006-2013), the global pharmaceutical and biotechnology industry has spent at least $930bn on drug research and development, according to data Scrip has accumulated from publicly-available company information.

Deals Of The Week Keeps Tabs As Tax Trimming Fuels Deal-Making

As more biopharmaceutical companies become profitable and global, tax strategy becomes an increasingly important aspect of deal-making and intellectual property management. Deals of the Week looks at recent tax winners, new tax tactics and potential deal targets that are attractive in part because of their high – or low – tax rates.

BioPharmaceutical Deals

Thailand’s BioNet-Asia On Developing Domestic Vaccines – An Interview With PharmAsia News

BioNet-Asia has carved a path in vaccines research in Thailand that faces the hurdle of attracting private funding while working on establishing proof of concept for pertussis and dengue vaccines. A mix of private capital and multinational alliances have helped nations such as Vietnam, Indonesia and Malaysia build up domestic vaccine capabilities.

BioPharmaceutical Thailand
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Peptide Therapeutics Group PLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Sanofi
  • Senior Management
  • Elizabeth Jones, CFO
    Michael Watson, PhD, EVP, R&D
  • Contact Info
  • Acambis PLC
    Phone: (44) 1223 275 300
    100 Fulbourn Rd.
    Cambridge, CBI 9PT
    UK
UsernamePublicRestriction

Register